Farydak (panobinostat) — Medica
Multiple Myeloma
Initial criteria
- Patient is currently receiving Farydak
- Patient has previously tried bortezomib injection
- Patient has tried one immunomodulatory drug (i.e., Thalomid [thalidomide capsules], lenalidomide capsules, or Pomalyst [pomalidomide capsules])
- Medication will be taken in combination with bortezomib injection and dexamethasone
Approval duration
1 year